The role of intra-abdominal chemotherapy in inoperable gastric cancer to change to operable tumor
Not Applicable
- Conditions
- Gastric cancer.Malignant neoplasm of stomach
- Registration Number
- IRCT201107257112N1
- Lead Sponsor
- iver and Gastrointestinal Diseases Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
presence of criteria for diagnosis as inoperable patient including: 1-local invasion to retroperitoneal organs including: Great veins like aorta-celiac body and solid organs like pancraces. 2 - peritoneal or omentum seeding or metastatic tumor like krukenberg tumor
Exclusion criteria: presence of ascites or metastasis, old age (more than 65 years old), cachectic patients with albumin less than 3 and edema
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method One year survival. Timepoint: 6 months after the end of trial. Method of measurement: Follow up the patients.;Quality of life. Timepoint: 6 months after the end of trial. Method of measurement: Follow up the patients.
- Secondary Outcome Measures
Name Time Method Tumor perforation. Timepoint: Beginning of trial to 6 months after trial. Method of measurement: Follow the patients and study quality of patient`s life.;Great vesseles perforation. Timepoint: Beginning of trial to 6 months after trial. Method of measurement: Follow the patients and study quality of patient’s life.;Vomitting. Timepoint: Beginning of trial to 6 months after trial. Method of measurement: Follow the patients and study quality of patient’s life.;Nausea. Timepoint: Beginning of trial to 6 months after trial. Method of measurement: Follow the patients and study quality of patient`s life.;Intra abdominal infection. Timepoint: Beginning of trial to 6 months after trial. Method of measurement: Follow the patients and study quality of patient’s life.